Evidence map›Paper›PMID 40908311›Full record

Trial reportJournal of perinatology : official journal of the California Perinatal Association2025

Gestational diabetes detection thresholds and infant growth, nutrition, and neurodevelopment at 12-18 months: a prospective cohort study within a randomized trial.

Francesca Amitrano, Komal Manerkar, Jane M Alsweiler, Cathryn A Conlon, Caroline A Crowther, Richard Edlin, Jane E Harding, Lesley Me McCowan, Michael P Meyer, Janet A Rowan and 2 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of perinatology : official journal of the California Perinatal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Francesca AmitranoLiggins Institute, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-8811-5886
Komal ManerkarLiggins Institute, University of Auckland, Auckland, New Zealand.
Jane M AlsweilerTe Whatu Ora, Te Toka Tumai Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-0874-6654
Cathryn A ConlonSchool of Sport, Exercise and Nutrition, Massey University, Auckland, New Zealand.
Caroline A CrowtherLiggins Institute, University of Auckland, Auckland, New Zealand.
Richard EdlinHealth Systems, University of Auckland, Auckland, New Zealand.
Jane E HardingLiggins Institute, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0003-2697-1422
Lesley Me McCowanDepartment of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.
Michael P MeyerTe Whatu Ora, Te Toka Tumai Auckland, Auckland, New Zealand.
Janet A RowanTe Whatu Ora, Te Toka Tumai Auckland, Auckland, New Zealand.
Elaine C RushSchool of Sport and Recreation, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
Christopher Jd McKinlayDepartment of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand. c.mckinlay@auckland.ac.nz.ORCID http://orcid.org/0000-0003-1088-9467

Funding

Auckland Medical Research Foundation (AMRF) 1115018Manatu Hauora | Health Research Council of New Zealand (HRC) 14/104
6 · The paper itself

Abstract

objectiveTo assess the impact of gestational diabetes(GDM) detection thresholds on infant growth, nutrition, and neurodevelopment at 12-18 months.

designProspective cohort study within the GEMS trial(ACTRN12615000290594), which randomized pregnant women to detection of GDM using lower or higher glycemic criteria. The main outcomes were overweight/rapid weight gain; food approach appetitive score; energy intake; cognitive z-score.

resultCompared to control infants, those exposed to GDM detected and treated by higher criteria or by lower but not higher criteria that was untreated, were less likely to have increased overweight/rapid weight gain, possibly with lower energy intake. There were no important differences in appetite and cognition. Infants exposed to GDM by lower but not higher criteria that was treated were similar to controls.

conclusionExposure to treated GDM or untreated GDM detected by lower but not higher criteria, was not associated with increased infant risk factors for obesity or adverse cognitive outcomes.

Indexed as

Child DevelopmentDiabetes, GestationalAdultBlood GlucoseCognitionEnergy IntakeFemaleHumansInfantMaleNutritional StatusPregnancyProspective StudiesRisk FactorsWeight GainBlood Glucose

Identifiers

PMID40908311
PMCPMC12479360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.